Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Simon

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Molecular Psychiatry|June 26, 2024
Social context and drug cues modulate inhibitory control in cocaine addiction: involvement of the STN evidenced through functional MRIDamiano Terenzi, Nicolas Simon, Michael Joe Munyua Gachomba, et al.
Plos One|July 9, 2016
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel StudyNicolas Simon, Michèle Vasseur, Marine Pinturaud, et al.
Metabolites|April 3, 2021
Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively?Fanny Moreau, Nicolas Simon, Julia Walther, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational StudyElodie Cuvelier, Houda Khazri, Cloé Lecluse, et al.
Plos One|June 26, 2020
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascitesLena Stockhoff, Marie Schultalbers, Tammo L Tergast, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
Clinical Pharmacology and Therapeutics|May 9, 2006
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humansLaurent Becquemont, Hartmut Glaeser, Siegfried Drescher, et al.
Trials|December 22, 2025
PREVENIR-IVF: study protocol for a prospective multicentre randomized open comparative trial, which explores the efficacy of a multidisciplinary platform reducing and preventing reprotoxic environmental exposures in subfertile couples on live birth rate after assisted reproduction treatmentClaire Sunyach, Blandine Courbiere, Nicolas Simon, et al.
BMC Psychiatry|June 1, 2022
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus studyPierre-Michel Llorca, Philippe Nuss, Éric Fakra, et al.
Microbial Cell Factories|July 23, 2024
Biosynthesis of a clickable pyoverdine via in vivo enzyme engineering of an adenylation domainHélène Puja, Laurent Bianchetti, Johan Revol-Tissot, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Molecular Psychiatry|June 26, 2024
Social context and drug cues modulate inhibitory control in cocaine addiction: involvement of the STN evidenced through functional MRIDamiano Terenzi, Nicolas Simon, Michael Joe Munyua Gachomba, et al.
Plos One|July 9, 2016
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel StudyNicolas Simon, Michèle Vasseur, Marine Pinturaud, et al.
Metabolites|April 3, 2021
Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively?Fanny Moreau, Nicolas Simon, Julia Walther, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational StudyElodie Cuvelier, Houda Khazri, Cloé Lecluse, et al.
Plos One|June 26, 2020
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascitesLena Stockhoff, Marie Schultalbers, Tammo L Tergast, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
Clinical Pharmacology and Therapeutics|May 9, 2006
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humansLaurent Becquemont, Hartmut Glaeser, Siegfried Drescher, et al.
Trials|December 22, 2025
PREVENIR-IVF: study protocol for a prospective multicentre randomized open comparative trial, which explores the efficacy of a multidisciplinary platform reducing and preventing reprotoxic environmental exposures in subfertile couples on live birth rate after assisted reproduction treatmentClaire Sunyach, Blandine Courbiere, Nicolas Simon, et al.
BMC Psychiatry|June 1, 2022
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus studyPierre-Michel Llorca, Philippe Nuss, Éric Fakra, et al.
Microbial Cell Factories|July 23, 2024
Biosynthesis of a clickable pyoverdine via in vivo enzyme engineering of an adenylation domainHélène Puja, Laurent Bianchetti, Johan Revol-Tissot, et al.
Pageof 21